Relationship of procollagen type III propeptide-related antigens in serum to somatic growth in healthy children and patients with growth disorders

This publication has 13 references indexed in Scilit:

• Long-Term Monitoring of Treatment with Recombinant Human Growth Hormone by Serial Determinations of Type III Procollagen-Related Antigens in Serum
  Pediatric Research, 1988
• Type 1 procollagen as a biochemical marker of growth in children with inflammatory bowel disease
  The Journal of Pediatrics, 1986
• Serum levels of aminoterminal type III procollagen peptide in normal subjects and hepatic fibrosis
  Gastroenterologia Japonica, 1985
• Variation in serum Type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis*
  European Journal of Clinical Investigation, 1985
• Serum and Urine Analysis of the Aminoterminal Procollagen Peptide Type III by Radioimmunoassay with Antibody Fab Fragments
  Collagen and Related Research, 1983
• Radioimmunoassay for type III procollagen peptide and its application to human liver disease
  European Journal of Clinical Investigation, 1979
• The Biosynthesis of Collagen and Its Disorders
  New England Journal of Medicine, 1979
• Estimation of Somatomedin-C Levels in Normals and Patients with Pituitary Disease by Radioimmunoassay
  Journal of Clinical Investigation, 1977
• Characterization of the Amino-Terminal Segment in Type III Procollagen
  European Journal of Biochemistry, 1976
• Urinary Total Hydroxyproline: Creatinine Ratio: Range of Normal, and Clinical Application in British Children
  Archives of Disease in Childhood, 1972